Doesn't matter!
What will be will be.
If the Whelans had any vision of implementing the 7 point plan for BIEL survival posted many times here, then we would have heard of it from them.
Failing that, clearly they want to risk it all and shareholders have little say, except through the SEC and all that can potentially bring down on the House of Whelan or civil litigation. All it takes is one disgruntled minority shareholder.
There are two things keeping the pps of the ActiPatch pain miracle in the toilet - the toxicity of the name involved and the management history of that aspect and the share structure. There is no other reason that can be holding the pps down in the toilet.
If the Whelans had the common sense to stay in the background for a couple of years AND fix the share structure, as suggested in October, I strongly believe the price would already be much, much higher.
Self-promoting and ego have driven the family to believe they have some kind of management touch or magic, whereas the fact is BIEL has been a financial mismanagement disaster from 2008 until February 2017 when foot and knee were FDA cleared and Keith Nalepka joined BIEL. That's when effective pursuit of sales began in earnest for Keith and Erin and still a Whelan said 'NO' to CVS, Scholl's and KT Tape between 2017and October 2019!
Full marks to Kelly Whelan for taking on BIEL. She may also have done it because NOT to do it may have meant personal financial discourse, but she really needs to 'get it right.'
And for my money, 'getting it right' means treating all shareholders fairly, not just her family, look forward, not back and fixing the share structure as suggested, it's killing the company, and now, not later! Stay off twitter, real CEO's don't use twitter, manage prudently, and get the job done using effective leadership.
